How to streamline comprehensive prenatal genetic testing with Fetal Focus™

How to streamline comprehensive prenatal genetic testing with Fetal Focus™

Join our upcoming live webinar with Q&A

Session 1: Tuesday, September 8, 2026 | 12 PM PT / 3 PM ET

Session 2: Wednesday, September 9, 2026 | 9 AM PT / 12 PM ET

Duration: 30-minute

Since the introduction of single-gene NIPT (sgNIPT) like Fetal Focus™, screening for inherited conditions like cystic fibrosis is more actionable than ever. As sgNIPT is integrated into routine prenatal genetic testing, providers need practical tools to streamline their workflows and simplify patient conversations.

Join Natera's Medical Director Dr. Amber Shamburger, who has over 15 years of clinical experience, as she shares her approach to discussing prenatal genetic testing with patients now that sgNIPTs can inform next steps after carrier findings.

Natera Medical Science Liaison Matt Herbst will highlight Natera’s latest tools and services that help clinicians integrate Fetal Focus™ sgNIPT into their workflow.

Learn more about:

Tools to streamline ordering, resulting, and tracking high-risk patients
How to simplify offering prenatal genetic testing for aneuploidy and single-gene conditions
New resources to support patient education before their visit and after results

Natera Honey Pot

Register Now:

First Name*

Last Name*

Email Address*

Job Title*

Phone*

Company Name*

Postal Code*

Country*

I am a*

Available Webinar Sessions*

Do you have any questions for the presenters that you would like to submit before the webinar?

Please fill in the field above only if you have specific questions. Otherwise, leave it blank.

Natera would like to send you information about our products and services. You may unsubscribe from these communications at any time.

Hear from our speakers

Amber Shamburger, MD, FACOG

Medical Director

Natera Women’s Health

Matt Herbst, MS, MBA

Medical Science Liaison

Natera Women’s Health

The tests described have been developed and their performance characteristics determined by the CLIA-certified laboratory performing the tests. The tests have not been cleared or approved by the US Food and Drug Administration (FDA). CAP accredited, ISO 13485 certified, and CLIA certified. © 2026 Natera, Inc. All Rights Reserved.

13011 McCallen Pass, Building A Suite 100 | Austin, TX 78753 | natera.com | Do Not Share My Personal Information | Privacy Policy